Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The translational element of the WIN consortium

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 25.04.19
Views: 784

Dr Brian Leyland-Jones - WIN Head of Fundraising Committee

Dr Brian Leyland-Jones speaks to ecancer about the upcoming WIN symposium and his role as lead fundraiser.

He begins by outlining the high profile leaders of the WIN consortium, and why this has led to great successes throughout WIN's history.

Dr Leyland-Jones also describes why WIN focuses on the translational aspect of precision oncology, and what the challenges are involved in this.

Related videos

follow us

SIOG metastatic renal cell carcinoma

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation